Pharma channel feed

As­traZeneca amps en­vi­ron­men­tal goals with deal for re­new­able fu­el use at all US sites

Last year
Deals
Marketing

La­dy Gaga takes cen­ter stage in Pfiz­er's Nurtec mi­graine cam­paign

Last year
Marketing

What to ex­pect from this year's Cannes Li­ons phar­ma and health awards

Last year
Marketing

Tele­health mar­keter Ro pulls its We­govy ad­ver­tis­ing amid on­go­ing sup­ply short­ages

Last year
Marketing

Pend­ing FDA's OK, Te­va and Alvotech can bring their Ste­lara biosim­i­lar to US mar­ket by 2025

Last year

Charles Riv­er to work with Cu­ri­gin on gene ther­a­py treat­ment

Last year
Cell/Gene Tx
Manufacturing

VM­LY&R Health spot­lights 'craft' in phar­ma ad­ver­tis­ing with new glob­al chief

Last year
Marketing

Am­gen and Hori­zon ar­gue FTC's suit to block $28B merg­er is 'as mis­guid­ed as it is un­prece­dent­ed'

Last year

Once promis­ing can­cer ther­a­py start­up On­corus ad­mits de­feat af­ter lay­ing off most of its staff

Last year
Startups

Ot­su­ka en­cour­ages Gen Z self-ex­pres­sion and 'liv­ing bold­ly' with men­tal health con­di­tions

Last year
Marketing

No­vo Nordisk ups in­vest­ment in Den­mark API man­u­fac­tur­ing fa­cil­i­ty to $2.3B

Last year
Manufacturing

No­var­tis adds $3.2B cash deal to M&A tal­ly, snap­ping up Chi­nook and its late-stage kid­ney drugs

Last year
Deals

FDA ad­comm votes unan­i­mous­ly in fa­vor of full ap­proval for Ei­sai's new Alzheimer's drug

Last year
FDA+

In an­nu­al re­port, FDA de­tails how it han­dled drug short­ages in 2022

Last year
Manufacturing

Te­va joins fel­low phar­mas in re­strict­ing 340B dis­counts

Last year

Ei­sai cy­ber at­tack leads to in­ves­ti­ga­tion of po­ten­tial da­ta leaks amid grow­ing in­dus­try threat

Last year

Phar­ma finds TV ads are a hard habit to break. It's still putting 65% of ad dol­lars in­to TV

Last year
Marketing

Sec­ond round of in­fla­tion-re­lat­ed re­bates hits 43 drugs from Am­gen, Seagen, Ab­b­Vie and oth­ers

Last year
Law

Amid AD­HD drug short­age, Ak­ili aims for adults with over-the-counter video game treat­ment

Last year
Marketing

San­doz an­tic­i­pates ad­di­tion­al $3B in po­ten­tial net sales over five years in pipeline ex­pan­sion

Last year

Q2 deal ac­tiv­i­ty points to po­ten­tial 'bumper year' for phar­ma — re­port

Last year
Deals

No­var­tis joins the film fes­ti­val cir­cuit with doc­u­men­tary se­ries on mis­un­der­stood skin dis­ease

Last year
Marketing

Tiny biotech takes on mR­NA vac­cine jug­ger­nauts in fed­er­al court in patent in­fringe­ment cas­es

Last year
Law

FDA shuts down Intar­ci­a's re­quests to de­vi­ate from typ­i­cal post-CRL hear­ing process

Last year
First page Previous page 117118119120121122123 Next page Last page
A service from the Financial Times